23 May 2013
Keywords: encouraging, data, mabthera, ra, phase, ii, dancer
Article | 20 June 2005
Data from the Phase II DANCER (Dose-Ranging Assessment iNternational Clinical Evaluation of Rituximab in RA) study, presented at the European
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 June 2005
18 July 2005
22 May 2013
© 2013 thepharmaletter.com